Hg. Shertzer et al., ENZYME-INDUCTION BY L-BUTHIONINE (S,R)-SULFOXIMINE IN CULTURED MOUSE HEPATOMA-CELLS, Chemical research in toxicology, 8(3), 1995, pp. 431-436
Induction of Phase II enzymes of the [Ah] gene battery by L-buthionine
(S,R)-sulfoximine (BSO) and other agents was examined in mouse hepato
ma Hepa-1c1c7 cells. BSO, a nonelectrophilic inhibitor of gamma-glutam
ylcysteine synthetase (GCS), is routinely used to examine the toxicolo
gical implications of GSH depletion. Exposure to BSO for 24 h produced
a 75-85% depletion of GSH levels, proportional to the inhibition of G
CS activity, as well as small increases in the UDP-glucuronosyltransfe
rase (UGT, 60%) and glutathione transferase (GST, 30%) enzyme activiti
es in Hepa-1 wild-type (wt) cells. However, for the NAD(P)H:menadione
oxidoreductase (NMO1) and cytosolic aldehyde dehydrogenase class 3 (AH
D4) enzyme activities, BSO produced larger increases (110% and 170%, r
espectively). The mechanisms of NMO1 and AHD4 induction were examined
further. In Hepa-l wt cells, NMO1 and AHD4 activities were increased b
y the aromatic hydrocarbon inducer 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD) and by the electrophile tert-butylhydroquinone (tBHQ), known i
nducing agents for these enzymes. However, NMO1 and AHD4 were induced
in Ah receptor nuclear translocation-defective mutant (c4) cells by BS
O and tBHQ, but not by TCDD, suggesting that the induction by BSO and
tBHQ is not Ah receptor-mediated. In wt cells, N-acetylcysteine produc
ed a concentration-dependent increase in intracellular cysteine levels
, but not GSH levels, in the absence or presence of BSO. Furthermore,
N-acetylcysteine had no effect on NMO1 activity under any conditions e
xamined, suggesting that GSH levels per se, rather than change in over
all thiol status, might be mediating increased NMO1 activity. The incr
ease in NMO1 was accompanied by increased mRNA; actinomycin D prevente
d the increases in both NMO1 enzyme activity and mRNA levels. Converse
ly, N-acetylcysteine significantly increased AHD4 activity in the abse
nce, but not the presence, of BSO. Although no increase in AHD4 mRNA w
as observed following BSO treatment, actinomycin D partially prevented
the increase in enzyme activity. These results suggest that GSH deple
tion by BSO might be correlated with inducing NMO1 and AHD4 activities
. Furthermore, the data suggest that the electrophile response element
(EpRE)-binding complex of the Nmol gene might differ from that of the
Ahd4 gene. Transcriptional activation appears to be responsible for t
he increased NMO1, and possibly in part for the increased AHD4 activit
y. A model is proposed whereby transcription of genes under the contro
l of an EpRE, such as that found in the regulatory region of all four
[Ah] battery Phase II genes, might be controlled by the state of redox
-active cysteinyl sulfur(s) contained in one or more EpRE-binding prot
ein(s). We propose that the collection of genes that are under partial
control of an EpRE be termed the ''electrophile response element'' [E
pRE] gene battery.